WP1

Clinical
Studies

WP2

Biomarker
measurements

WP3

Data management & MOMICS prediction

WP4

Translation,
exploitation and
IP management

WP5

Methodology,
ethics &
economic evaluation

WP6

Project Management, communication and dissemination

WP2

Biomarker measurements

Objectives

To deliver rapid biomarker measurements in patients with HT included in the clinical trials in WP1.

WP leader

Main contributors

WP3

Data management & MOMICS prediction

Objectives

To build the computational platform to deliver an innovative predictor of EHT and treatment response to the clinic.

WP leader

Main contributors

WP4

Translation, exploitation and IP management

Objectives

To prepare implementation of MOMICS biomarkers as companion diagnostics for patients with HT and their exploitation for clinical use.

WP leader

Main contributors

WP5

Methodology, ethics & economic evaluation

Objectives

To provide methodological support for clinical assays in WP1, address ethical, legal and regulatory issues, and provide an economic evaluation of the use of omics on patients' care pathways, outcomes and costs.

WP leader

Main contributors

WP6

Project Management, communication and dissemination

Objectives

This WP will ensure the management, communication and dissemination, exploitation and IP management of HT-ADVANCE.

WP leader

Main contributors

WP1

Clinical studies

Objectives

To assess the diagnostic performance of MOMICS biomarkers for identification of EHT and PHT, and the ability of MOMICS biomarkers to predict treatment response to antihypertensive agents in hypertensive subjects.

WP leader

Main contributors